Leukemia Program Head

Position

Professor, Clinician/Scholar or Physician/Scientist – Leukemia Program Head

The Fred Hutchinson Cancer Center (Fred Hutch) and the University of Washington (UW) invite nominations and applications to lead the Leukemia Program. The Program Head will oversee research and clinical programs in acute myeloid leukemia (AML) and other myeloid malignancies. The role is dual‑appointed: a primary faculty appointment in the Translational Science and Therapeutics Division or the Clinical Research Division at Fred Hutch, and a secondary appointment in the UW Department of Medicine, Division of Hematology and Oncology.

• Strategically guide the Leukemia Program, ensuring alignment with institutional mission and goals.
• Develop and implement a comprehensive vision and strategy for AML and myeloid malignancies across the entire disease spectrum.
• Lead and support groundbreaking research initiatives, including preclinical studies, clinical trials, and translational research.
• Foster collaborations with bench researchers, translational researchers, clinical investigators at UW and Fred Hutch, and external industry partners, regulatory agencies, and funding organizations.
• Act as an academic, clinical, and educational leader: organize, direct, and expand research efforts for a team of clinical researchers conducting trials.
• Assist with faculty recruitment, oversight, and mentorship; promote professional development for team members.
• Represent the Program at national and international conferences, workshops, and symposia.
• Maintain relationships with external stakeholders and support grant and funding activities.

• MD/DO degree (or foreign equivalent).
• Board certification in hematology and/or medical oncology (or foreign equivalent).
• Eligibility for medical licensure in the state of Washington.
• Record of substantial basic, translational, and/or clinical research in AML and/or myeloid malignancies, evidenced by peer‑reviewed publications, grants, and/or clinical trial experience.
• International reputation for leadership in AML and/or myeloid malignancies research and clinical excellence.
• Proven ability to secure NIH grant funding and successful track record of publishing.

• Comprehensive benefits package including medical/vision, dental, flexible spending accounts, life, disability, retirement, family life support, employee assistance program, on‑site health clinic, tuition reimbursement.
• Paid vacation (22 days per year), paid sick leave (up to 30 calendar days per qualifying occurrence), paid holidays (up to 13 days per year), and paid parental leave (up to 4 weeks).
• Eligible for relocation assistance or sign‑on bonus; potential administrative supplement (ADS) in addition to base salary.

July 1, 2025

We are proud to be an Equal Employment Opportunity (EEO) and Vietnam Era Veterans Readjustment Assistance Act (VEVRAA) employer. We do not discriminate on the basis of race, color, religion, creed, ancestry, national origin, sex, age, disability (physical or mental), marital or veteran status, genetic information, sexual orientation, gender identity, political ideology, or membership in any other legally protected class. We desire priority referrals of protected veterans.

If due to a disability you need assistance or a reasonable accommodation during the application or recruitment process, please send a request to Human Resources at hrops or by calling 206‑667‑4700.